Susan E Burwig
CIK 1677418 · View on SEC EDGAR ↗
First SEC filing: Aug. 10, 2016 · Latest: Aug. 10, 2016
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 28, 2026 | MEDP | S | 7,500 | $600.00 | $4,500,000 | 62,984 Direct | -10.64% | Disposed | 1.2% (price as of 2026-08-19) |
| Dec. 15, 2023 | MEDP | S | 2,009 | $303.00 | $608,727 | 15,283 Direct | -11.62% | Disposed | 100.3% (price as of 2026-08-19) |
| Dec. 14, 2023 | MEDP | S | 10,391 | $304.15 | $3,160,423 | 17,292 Direct | -37.54% | Disposed | 99.6% (price as of 2026-08-19) |
| Aug. 17, 2016 | MEDP | P | 18,000 | $29.20 | $525,600 | 19,211 Direct | +1486.37% | Acquired | 1978.6% (price as of 2026-08-19) |
| Aug. 16, 2016 | MEDP | P | 1,211 | $29.30 | $35,482 | 1,211 Direct | — | Acquired | 1971.5% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 23, 2023 | MEDP | Employee Stock Option (Right to Buy) | Common Stock (7,500) | $32.05 | Feb. 28, 2025 | 7,500 | Disposed |
| Feb. 28, 2018 | MEDP | Employee Stock Option (Right to Buy) | Common Stock (15,000) | $32.05 | Feb. 28, 2025 | 15,000 | Acquired |
| March 15, 2017 | MEDP | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | COMMON STOCK (20,000) | $28.32 | March 15, 2024 | 20,000 | Acquired |
| Aug. 10, 2016 | MEDP | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | Common Stock (7,400) | $23.00 | Aug. 10, 2023 | 7,400 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 10, 2016 | MEDP | Employee Stock Option (right to buy)→ Common Stock (37,037) | 37,037 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MEDP
EVP| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $710,417 | $497,400 | — | — | — | — | $15,922 | $2,723,814 |
| 2024 | $671,667 | $352,700 | — | — | — | — | $39,702 | $4,834,069 |
| 2023 | $598,100 | $418,880 | — | — | — | — | $107,319 | $1,124,299 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.